170 related articles for article (PubMed ID: 31325604)
1. Integrative Chinese herbal medicine therapy reduced the risk of type 2 diabetes mellitus in patients with polycystic ovary syndrome: A nationwide matched cohort study.
Liao WT; Su CC; Lee MT; Li CJ; Lin CL; Chiang JH; Yen HR
J Ethnopharmacol; 2019 Oct; 243():112091. PubMed ID: 31325604
[TBL] [Abstract][Full Text] [Related]
2. The prescription patterns of traditional Chinese medicine for women with polycystic ovary syndrome in Taiwan: A nationwide population-based study.
Lin MJ; Chen HW; Liu PH; Cheng WJ; Kuo SL; Kao MC
Medicine (Baltimore); 2019 Jun; 98(24):e15890. PubMed ID: 31192922
[TBL] [Abstract][Full Text] [Related]
3. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome.
Joham AE; Ranasinha S; Zoungas S; Moran L; Teede HJ
J Clin Endocrinol Metab; 2014 Mar; 99(3):E447-52. PubMed ID: 24081730
[TBL] [Abstract][Full Text] [Related]
4. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
[TBL] [Abstract][Full Text] [Related]
5. Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study.
Ryu KJ; Kim MS; Kim HK; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T; Park H
Fertil Steril; 2021 Jun; 115(6):1569-1575. PubMed ID: 33509630
[TBL] [Abstract][Full Text] [Related]
6. The use of Chinese herbal medicine as an adjuvant therapy to reduce incidence of chronic hepatitis in colon cancer patients: A Taiwanese population-based cohort study.
Lin TH; Yen HR; Chiang JH; Sun MF; Chang HH; Huang ST
J Ethnopharmacol; 2017 Apr; 202():225-233. PubMed ID: 28330722
[TBL] [Abstract][Full Text] [Related]
7. Standardised versus individualised multiherb Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: a randomised feasibility and pilot study in the UK.
Lai L; Flower A; Prescott P; Wing T; Moore M; Lewith G
BMJ Open; 2017 Feb; 7(2):e011709. PubMed ID: 28159846
[TBL] [Abstract][Full Text] [Related]
8. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
Lu HL; Su YC; Lin MC; Sun MF; Huang ST
Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062
[TBL] [Abstract][Full Text] [Related]
9. Integrated Chinese and Western Medicine for Coronary Heart Disease Prevention in Polycystic Ovary Syndrome: A 19-Year Nationwide Cohort Study.
Liao CC; Chien CH; Yu TS; Li JM
J Multidiscip Healthc; 2023; 16():3959-3973. PubMed ID: 38089784
[TBL] [Abstract][Full Text] [Related]
10. Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome.
Ong M; Peng J; Jin X; Qu X
Am J Chin Med; 2017; 45(3):405-422. PubMed ID: 28359195
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study.
Ding T; Hardiman PJ; Petersen I; Baio G
Hum Reprod; 2018 Jul; 33(7):1299-1306. PubMed ID: 29684121
[TBL] [Abstract][Full Text] [Related]
12. Increased Risk of Polycystic Ovary Syndrome in Taiwanese Women with Chronic Periodontitis: A Nationwide Population-Based Retrospective Cohort Study.
Tong C; Wang YH; Yu HC; Chang YC
J Womens Health (Larchmt); 2019 Oct; 28(10):1436-1441. PubMed ID: 31145020
[No Abstract] [Full Text] [Related]
13. Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome.
Rubin KH; Glintborg D; Nybo M; Abrahamsen B; Andersen M
J Clin Endocrinol Metab; 2017 Oct; 102(10):3848-3857. PubMed ID: 28938447
[TBL] [Abstract][Full Text] [Related]
14. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study.
Hung KF; Hsu CP; Chiang JH; Lin HJ; Kuo YT; Sun MF; Yen HR
J Ethnopharmacol; 2017 Mar; 199():168-174. PubMed ID: 28163114
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome.
Kakoly NS; Earnest A; Teede HJ; Moran LJ; Joham AE
Diabetes Care; 2019 Apr; 42(4):560-567. PubMed ID: 30705063
[TBL] [Abstract][Full Text] [Related]
16. A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome.
Shen CC; Yang AC; Hung JH; Hu LY; Tsai SJ
Oncologist; 2015 Jan; 20(1):45-9. PubMed ID: 25410097
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
Kuek S; Wang WJ; Gui SQ
Zhong Xi Yi Jie He Xue Bao; 2011 Sep; 9(9):965-72. PubMed ID: 21906521
[TBL] [Abstract][Full Text] [Related]
18. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Zhang J; Li T; Zhou L; Tang L; Xu L; Wu T; Lim DC
Cochrane Database Syst Rev; 2010 Sep; (9):CD007535. PubMed ID: 20824862
[TBL] [Abstract][Full Text] [Related]
19. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
[TBL] [Abstract][Full Text] [Related]
20. [Clinical observation on treatment of 43 women with polycystic ovary syndrome based on syndrome differentiation].
Jia LN; Wang XJ
Zhong Xi Yi Jie He Xue Bao; 2006 Nov; 4(6):585-8. PubMed ID: 17090372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
